DocuSign (DOCU) director Wilderotter exercises options and sells 3,000 shares

Rhea-AI Filing Summary

DOCUSIGN, INC. director Mary Agnes Wilderotter exercised stock options and sold shares in a routine transaction. She exercised options for 3,000 shares of Common Stock at an exercise price of $17.66 per share, then sold 3,000 shares at $48.15 per share on the same date.

After these transactions, she directly held 59,803 shares of DocuSign common stock. The derivative position tied to this specific option grant was fully exercised, with no remaining options from this grant shown in the filing.

Insider Trade Summary

Net Seller: 3,000 shares ($144,450)

Net Sell 3 txns

Insider Wilderotter Mary Agnes

Role Director

Sold 3,000 shs ($144K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	3,000	$0.00	--
Exercise	Common Stock	3,000	$17.66	$53K
Sale	Common Stock	3,000	$48.15	$144K

Holdings After Transaction: Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 62,803 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Options exercised: 3,000 shares Exercise price: $17.66 per share Shares sold: 3,000 shares +3 more

6 metrics

Options exercised 3,000 shares Stock options converted to common stock on April 1, 2026

Exercise price $17.66 per share Strike price of the exercised stock option

Shares sold 3,000 shares Open-market sale on April 1, 2026

Sale price $48.15 per share Price received in the reported sale

Shares owned after 59,803 shares Direct DocuSign holdings after the transactions

Option expiration June 16, 2026 Original expiration date of the exercised option

Key Terms

Stock Option (Right to Buy), derivative security, open-market sale, vesting, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

vesting financial

"footnote: "1/24th of the shares subject to the option vested each month""

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

exercise price financial

"conversion_or_exercise_price: "17.6600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilderotter Mary Agnes

(Last) (First) (Middle)

C/O DOCUSIGN, INC.

221 MAIN STREET, SUITE 800

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		M		3,000	A	$17.66	62,803	D
Common Stock	04/01/2026		S		3,000	D	$48.15	59,803	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$17.66	04/01/2026		M			3,000	(1)	06/16/2026	Common Stock	3,000	$0	0	D

Explanation of Responses:

1. 1/24th of the shares subject to the option vested each month beginning on 5/20/16, subject to the Reporting Person continuing to be a service provider on such dates.

Remarks:

	/s/ Derrick Chapman, Attorney-in-fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did DocuSign (DOCU) director Mary Agnes Wilderotter report in this Form 4?

Mary Agnes Wilderotter reported exercising stock options for 3,000 DocuSign shares at $17.66 and selling 3,000 shares at $48.15. The filing reflects a routine exercise-and-sell transaction by a director and updates her direct ownership after these trades.

How many DocuSign (DOCU) shares did Mary Agnes Wilderotter sell and at what price?

She sold 3,000 shares of DocuSign common stock at $48.15 per share. This followed the exercise of stock options for the same number of shares, converting options into stock and then disposing of those shares in an open-market sale.

At what price did Mary Agnes Wilderotter exercise her DocuSign (DOCU) stock options?

She exercised stock options at an exercise price of $17.66 per share for 3,000 underlying DocuSign common shares. This option grant had a vesting schedule described in the footnote and was fully exercised in this transaction, leaving no remaining options from that grant.

How many DocuSign (DOCU) shares does Mary Agnes Wilderotter hold after this Form 4 transaction?

After the reported transactions, Mary Agnes Wilderotter directly owns 59,803 shares of DocuSign common stock. This figure comes from the Form 4 and reflects her holdings immediately following the option exercise and subsequent sale of 3,000 shares.

What type of transaction is shown in this DocuSign (DOCU) Form 4 for Mary Agnes Wilderotter?

The Form 4 shows an exercise-and-sell pattern. She exercised a stock option (a derivative security) for 3,000 DocuSign shares and then sold 3,000 common shares in an open-market sale, updating her direct equity position as a company director.

Does Mary Agnes Wilderotter still have options remaining after this DocuSign (DOCU) Form 4?

The filing shows she exercised 3,000 option shares and that the related derivative position went to zero. No remaining options from this particular grant appear, and the derivative summary is empty for additional derivative holdings in this specific report.